LAUR-601

LAUR-601 is a preclinical **V-Smart nanoparticle nanomedicine** being developed by Lauren Sciences for **Alzheimer's disease**. The candidate is engineered to deliver **brain-derived neurotrophic factor** as a **protein therapeutic payload** to **degenerating brain neurons** in the central nervous system. Its intended mechanism is neurotrophic support through BDNF signaling, including activation of the **TrkB pathway**, with the V-Smart platform designed to enable CNS delivery of the payload after systemic administration. Company pipeline materials indicate the program is in **preclinical development**, with work described as **in progress**.

Other names

V-Smart BDNF nanomedicineBDNF V-Smart nanomedicine